Health
Gout drug could reduce Covid hospital stays, new research finds – The Guardian
Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings
A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.
The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.
Colchicine, which is used to treat rheumatic diseases, was hailed by researchers as having the potential to be the…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business15 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today